id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
CDC-2017-0017-0004,CDC,CDC-2017-0017,NIOSH Response to comments received on Level of Evidence,Supporting & Related Material,,2017-10-19T04:00:00Z,2017,10,,,2017-10-19T12:05:45Z,,0,0,0900006482b8bbd1
CDC-2017-0017-0002,CDC,CDC-2017-0017,NIOSH Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations,Supporting & Related Material,,2017-09-27T04:00:00Z,2017,9,,,2017-09-27T13:16:16Z,,0,0,0900006482b81076
CDC-2017-0017-0003,CDC,CDC-2017-0017,Revised Final Document - NIOSH Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations,Supporting & Related Material,,2017-09-27T04:00:00Z,2017,9,,,2017-09-27T13:21:48Z,,0,0,0900006482b8197d
CDC-2017-0017-0001,CDC,CDC-2017-0017,Proposed Revised Definitions for the Levels of Evidence for NIOSH Skin Notation Profiles; Request for Comment,Notice,,2017-03-09T05:00:00Z,2017,3,2017-03-09T05:00:00Z,2017-04-11T03:59:59Z,2017-03-09T12:29:20Z,2017-04628,0,0,09000064824fb28a